The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Stocks•6 May 2026•

1 min read

Legal Probes Hit Merchants Bancorp and Qiagen Following Financial Performance Misses

Key Facts

1Merchants Bancorp shares fell 9.3% following a 50% year-over-year collapse in brokered deposits.

2Levi & Korsinsky initiated investigations into officers and directors of Merchants Bancorp and Qiagen for potential fiduciary duty breaches.

3Qiagen reported a 5% decline in Q1 2026 QuantiFERON volumes, missing its previous low single-digit growth projection.

Law firm Levi & Korsinsky has launched formal investigations into the officers and directors of Merchants Bancorp and Qiagen regarding potential breaches of fiduciary duties. The probe follows a sharp 9.3% decline in Merchants Bancorp shares after the company revealed a 50% year-over-year collapse in brokered deposits. Simultaneously, Qiagen is under scrutiny after reporting a 5% decline in QuantiFERON volumes for Q1 2026, missing its previous growth projections. These operational misses have triggered concerns over the transparency of financial disclosures provided to the market. The legal investigations aim to determine if shareholder interests were compromised during these periods of financial volatility. Investors are closely monitoring the situation as these probes could escalate into significant shareholder litigation.

Version History

1 additional source confirmed this story